---
title: "Kyiv's 'Farmacia' chain explains temporary shortage of imported drugs and appeals to residents"
description: "The municipal pharmacy chain 'Farmacia' in Kyiv explained the temporary shortage of certain imported drugs as the result of damage to warehouse facilities during the September attacks on pharmaceutical infrastructure, and asked residents not to build up excess stockpiles."
date: 2026-09-16T21:44:01.000Z
lang: en
url: https://xab.info/en/posts/farmacia-temporary-shortage-of-imported-drugs-kyiv
tags: [pharmacy, medicine-shortage, kyiv, logistics, chronic-disease, ukraine]
publisher: "XAB.info"
---

# Kyiv's 'Farmacia' chain explains temporary shortage of imported drugs and appeals to residents

![A pharmacist from the Farmacia chain consults a customer at the pharmacy counter with medicine boxes and shelves in the background](https://xab.info/media/2026/09/17/farmacia-vremennyj-deficit-lekarstv-kiev/farmacia-vremennyj-deficit-lekarstv-kiev-1.webp)

## 🎯 Key Points

- The 'Farmacia' chain is temporarily short on certain imported drugs and medicines for chronic diseases due to damage to warehouse facilities
- The disruptions are a consequence of a series of strikes on pharmaceutical infrastructure in early September, including the destruction of the 'Apteka Dobroho Dnia' warehouse and damage to the Teva and 'Biokon' storage facilities
- The company is asking Kyiv residents not to build up excess stockpiles, in order to ensure access to drugs for patients who genuinely need them

The municipal pharmacy chain 'Farmacia' has recorded a temporary reduction in the availability of certain imported medicines and drugs used to treat chronic diseases. Company representatives explained that the situation is caused by disruptions in the logistics chains of manufacturers and suppliers: damage to warehouse facilities where medicines were stored has affected the timely delivery of certain drugs to the pharmacy network. According to the company, as of 17 September 2026, the disruptions are localized and affect a limited list of products.

### Cause of the disruptions: damage to warehouse infrastructure

As clarified by 'Farmacia', the key factor was the physical damage to warehouse complexes where stocks of imported medicines were concentrated. The destruction or partial loss of storage facilities meant that some batches of drugs became unavailable for further distribution logistics. The company emphasizes that this is not a systemic absence of medicines, but a temporary breakdown in the 'manufacturer — warehouse — pharmacy' chain, which hampers the timely replenishment of the range in retail outlets.

### Demand for drugs for chronic patients is gradually stabilizing

The company notes that the initial surge in demand for medicines, driven by fears of further shortages, is already beginning to ease. Nevertheless, drugs for the treatment of chronic diseases — those that patients take on a course and cannot afford to miss doses of — remain in a zone of heightened attention. 'Farmacia' continues to work with suppliers and partners to restore stable logistics and replenish the range of items for which demand remains elevated. The network's specialists are exploring all available alternative supply routes to shorten the period needed to restore the required range.

### Appeal to Kyiv residents: do not build up excess stockpiles

'Farmacia' has appealed to the residents of Kyiv, asking them not to build up excessive stockpiles of medicines without a real need. The company explains that panic hoarding of drugs in personal reserves creates an artificial shortage on the shelves and deprives access to necessary medicines of those patients who need them right now. According to the network's management, the situation is under constant control: as supply resumes, the availability of medicines in pharmacies will gradually increase.

### Context: the September series of strikes on pharmaceutical infrastructure

The current disruptions at 'Farmacia' are a direct consequence of a series of attacks on pharmaceutical infrastructure carried out in early September. According to available data, on 3 September, as a result of a Russian attack, a consignment of medicines belonging to the company 'Apteka Dobroho Dnia' was destroyed, resulting in the loss of hundreds of tons of medicines that were to be delivered to patients in various regions of Ukraine. During the same period, other major logistics complexes were also affected: warehouses of the pharmaceutical giant Teva and of the company 'Biokon' were damaged. The cumulative impact of these incidents on the industry's warehouse and distribution network is what has led to the temporary shortages now observed in retail pharmacy chains, including 'Farmacia'.

## 🔍 Fact-Check Verification

- [Some medicines temporarily in short supply in Kyiv: 'Farmacia' explains the cause and appeals to residents](https://www.rbc.ua/ukr/news/kievi-timchasovo-brakue-deyakih-likiv-farmatsiya-1789594873.html) - Источник подтверждает факт временного дефицита в сети «Фармация», объяснение причины (повреждение складов), призыв к жителям не создавать запасы. Совпадает с первичным текстом.
- ['The break is life-threatening': complaints about a shortage of epilepsy drugs in Kazakhstan](https://tengrinews.kz/tengri-health/pereryiv-opasen-jizni-kazahstane-jaluyutsya-defitsit-592253/) - Источник описывает проблему дефицита противосудорожных препаратов в Казахстане. Не связан с украинской темой и сетью «Фармация». В статью не включён.

## ❓ FAQ

### Q: Which specific medicines are in short supply at the 'Farmacia' chain?
**A:** The company points to a temporary reduction in the availability of certain imported medicines and drugs for the treatment of chronic diseases. The specific list of products is not disclosed in the public statement.

### Q: What caused the supply disruptions?
**A:** According to representatives of 'Farmacia', the cause was the disruption of logistics chains due to damage to warehouse facilities where medicines were stored. This occurred as a result of a series of attacks on pharmaceutical infrastructure in early September 2026.

### Q: How long will the shortage last?
**A:** The company does not give exact timelines for restoring the range. 'Farmacia' reports that the situation is under constant control and that, as supply resumes, the availability of medicines in pharmacies will gradually increase.

### Q: What are patients with chronic diseases advised to do?
**A:** The company asks that excessive stockpiles not be built up without necessity, in order to ensure access to drugs for all those in need. At the same time, drugs for chronic patients remain a priority when distributing limited remaining stocks.